Citius

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise $166 Million.

Hepion (HEPA) Banked $88 Million Yesterday, Citius (CTXR) Banks $78 Million Today. We're beginning to believe (and...

Video: Mel Gibson Stem Cell Testimonial.

Fascinating Interview with Joe Rogen, Mel Gibson, and Dr. Neil Riordan, Early Pioneer and Stem Cell Expert. Joe Rogan...

Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.

Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again.. The Microsoft co-founder...
Good Clinic, Biotech Stock Review

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

LIVE QUOTE Nice chart ahead of its first clinic opening.. By George, they did...
CB Scientific

CB Scientific (CBSC): News Archive

Recent Headlines Continously Updated April 8th, 2021. My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application,...
CB Scientific, Biotech Stock Review, Telehealth

Report: My-Cam™ and My-Cardia™ the Ultimate ‘Any-Doctor-Anywhere’ Telehealth Monitoring Application.

New and Updated Report on CB Scientific (CBSC) $1.05. Revolutionary Any-Doctor-Any Where, at Home Heart Rate Monitor, can...

Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.

The 2021 Biotech Six Pack: Stocks We Expect to Double! These are ideas #3 and #4 for the 'Biotech...

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
CB Scientific

Philips (PHG) Completes the Acquisition of BioTelemetry, Inc.

Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...